fashion -WSS

fashion

author：leisure time 2025-09-29 22:52:44 - browse：28623

Illustration of researchers working among oversized pill bottles, lab equipment, and medicine for story about the development of obesity medications – health and pharma coverage from STAT — Molly Ferguson for STAT

The exploding popularity of drugs like Wegovy and Mounjaro has propelled dozens of companies to develop their own obesity treatments, with most of them trying to emulate the same approach as the blockbuster products.

Nearly 70 obesity treatments are in development, and about two-thirds use a similar mechanism as Wegovy and Mounjaro, according to the STAT Obesity Drug Tracker, a new database compiled by STAT. There are also a minority of companies pursuing entirely different approaches, hoping that they will stand out among the field.

The tracker, which will be updated with significant developments each quarter, gives a sense of what new mechanisms could hit the market, how they would be delivered, and which companies are running the most trials.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Burning questions for the 2024 JPM Healthcare Conference

WSS

J&J to buy cancer drug developer Ambrx Biopharma

Methadone doses haven’t kept up in the age of fentanyl

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

Man killed during FBI raid in connection with threats against Biden, other officials

Methadone doses haven’t kept up in the age of fentanyl

GSK Flovent asthma inhalers replaced by authorized generics

hotspot

fashion

explore

The high cost of giving birth even with insurance

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

How to save PrEP access — and even expand it

J&J to buy cancer drug developer Ambrx Biopharma

Medical leaders decry Supreme Court decision on affirmative action

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

Hepatitis C has a cure — but many Americans still lack access to it

Goldman Sachs launches $650M fund for life science investments

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

JPM: CVS says Medicare Advantage patients are impacting profits

knowledge

Drastic changes should bring profitability, startup health insurers say

Why psychiatrists like me stop taking insurance

The biotech scorecard for Q1: 17 stock

GSK Flovent asthma inhalers replaced by authorized generics

Drastic changes should bring profitability, startup health insurers say

Police still searching for prisoner who escaped from NYC hospital

knowledge

focus

focus

hotspot